Related Experiment Video
Updated: Mar 19, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
[Role of Rheb in Human Acute Myeloid Leukemia]
Xiao-Min Wang1, Qiao-Zhu Xu1, Ya-Nan Gao1
1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 30020, China.
Objective:
To investigate the role of Rheb (mTOR activator) in AML development by measuring Rheb expression in bone marrow of adult AML patients and in AML cell line HL-60.
Methods:
Real-time PCR assay was used to measure the Rheb mRNA expression in 27 AML patients and 29 ITP patients as control. The relationship between Rheb mRNA expression and age, AML subtype, fusion gene, splenomegaly, hepatomegaly and survival of AML patients was analyzed and compared. In addition, HL-60 cell line over-expressing Rheb was established, and the HL-60 cells and HL-60 cells with overexpression of Rheb were treated with Ara-C of different concentrations, the proliferation level was detected by CCK-8 method, and the IC50 was calculated.
Results:
The mRNA level of Rheb in AML patients was similar to that in ITP patients (control). Interestingly, higher expression of Rheb was associated with better survival and was sensitive to Ara-C treatment. However, the expression level of Rheb was not associated with age, AML subtype, fusion gene, and hepatomegaly of patients. Lower expression level of Rheb was associated with splenomegaly. In vitro analysis of HL-60 line indicated that overexpression of Rheb could increased the cell sensitivity to Ara-C treatment (IC50=0.54 µmol/L) and caused HL-60 cell apoptosis.
Conclusion:
The lower Rheb expression is a poor prognostic indicator for AML patients, which is associated with AML splenomegaly, the patients and HL-60 cells with low expression of Rheb are insensitive to Ara-C treatment.
Insights
Low Rheb expression indicates a poor prognosis in acute myeloid leukemia (AML) patients, correlating with splenomegaly and reduced sensitivity to Ara-C treatment. Conversely, higher Rheb levels are linked to better survival outcomes.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- The role of Rheb, a Ras homologue and mTOR activator, in AML pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the prognostic significance of Rheb expression in adult AML patients.
- To determine the association between Rheb levels and clinical characteristics, including survival and response to chemotherapy.
Main Methods:
- Quantitative real-time PCR was used to measure Rheb mRNA levels in bone marrow samples from 27 AML patients and 29 controls.
- Correlation analysis was performed to assess the relationship between Rheb expression and clinical parameters.
- In vitro studies using the HL-60 AML cell line evaluated the impact of Rheb overexpression on cell proliferation and sensitivity to Ara-C.
Main Results:
- Rheb mRNA levels in AML patients were comparable to controls.
- Lower Rheb expression was associated with splenomegaly and poorer patient survival.
- Overexpression of Rheb in HL-60 cells enhanced sensitivity to Ara-C treatment and promoted apoptosis.
Conclusions:
- Reduced Rheb expression serves as a poor prognostic biomarker in AML.
- Low Rheb levels are linked to splenomegaly and chemoresistance, particularly to Ara-C.
- Targeting Rheb or understanding its pathway may offer therapeutic strategies for AML.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
09:51Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression
Published on: March 5, 2013
Related Concept Videos
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a...
Differentiation of Common Myeloid Progenitor Cells